SOPHARMA AD (the “Company”) hereby informs that from 13 March 2014 up to and including 19 March 2014 the Company bought 12 999 own shares representing 0.01% of the share capital of the Company, to the total value of 58 147.58 BGN on the Bulgarian Stock Exchange, the average price per share was 4.47 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 033 079, representing 3.81% of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 20 March 2014 up to and including 26 March 2014 the Company sold 8 894 own shares representing 0.007% of the share capital of the Company, to the total value of 40 702.95 BGN on the Bulgarian Stock Exchange, the average price per share was 4.58 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 024 185, representing 3.81% of the share capital of the Company.

We would like to notify that for the month of April, 2012 Sopharma AD realized increase of sales revenues of 15% compared with the same month of the previous year, including 6% decrease of domestic sales and 23% increase of export sales.

During the first four months of this year, Sopharma AD realized increase of sales revenues of 1%, including 15 % decrease of domestic sales and 8% increase of export sales compared with the same quarter of 2011.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 3 May 2012 up to and including 9 May 2012 the Company bought 700 own shares representing 0.00053% of the share capital of the Company, to the total value of BGN 1776.6 on the Bulgarian Stock Exchange. The average price per share was BGN 2.54.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 10 May 2012 up to and including 16 May 2012 the Company bought 3097 own shares representing 0.0023% of the share capital of the Company, to the total value of BGN 7515.54 on the Bulgarian Stock Exchange. The average price per share was BGN 2.427.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 17 May 2012 up to and including 23 May 2012 the Company bought 40800 own shares representing 0.031% of the share capital of the Company, to the total value of BGN 94444 on the Bulgarian Stock Exchange. The average price per share was BGN 2.314.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

SOPHARMA AD (the “Company”) hereby informs that from 17 April 2014 up to and including 23 April 2014 the Company bought 1 500 own shares representing 0.0011% of the share capital of the Company, to the total value of 6 575 BGN on the Bulgarian Stock Exchange, the average price per share was 4.38 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 4 988 435, representing 3.78% of the share capital of the Company.

SOPHARMA AD (the “Company”) notifies that for March 2014 the Company realized an increase of sales revenues of 16% compared to the same period of 2013, including 10% decrease of domestic sales and 32% increase of export sales.

During the past three months Sopharma AD recorded an increase of sales revenues of 6%, including 3% increase of domestic sales and 8% increase of export sales compared to 2013.

SOPHARMA AD (the “Company”) hereby informs that from 3 April 2014 up to and including 9 April 2014 the Company bought 26 925 own shares representing 0.02% of the share capital of the Company, to the total value of 119 498.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.44 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 4 982 810, representing 3.77% of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 10 April 2014 up to and including 16 April 2014 the Company bought 4 125 own shares representing 0.003% of the share capital of the Company, to the total value of 18 136.84 BGN on the Bulgarian Stock Exchange, the average price per share was 4.40 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 4 986 935, representing 3.78% of the share capital of the Company.